Incyte finalizes the acquisition of Escient Pharmaceuticals
Incyte yesterday announced that it has completed its acquisition of Escient Pharmaceuticals, a clinical-stage drug discovery and development company advancing novel small molecule therapeutics for systemic immune and neuro-immune disorders. “The acquisition of Escient and its first-in-class oral MRGPR antagonists bolsters our Inflammation and Autoimmunity portfolio and our commitment to creating innovative solutions that address […]
Battery Ventures invests in the Titian Software
Battery Ventures, a global, technology-focused investment firm, announced a significant, majority investment in Titian Software Ltd., a U.K. company that develops innovative sample-management software and related services for life-sciences laboratories. Specific terms were not disclosed. Titian, based in London, makes technology for the entire sample-management process, helping customers maximize the efficiency of their research and […]